Fresenius Archives - Journal for Clinical Studies

Current Edition

Regional News

CSL to buy Vifor for $11.7B in biopharma’s largest M&A deal this year

In a move to diversify its business, Australian biopharma CSL has agreed to acquire Vifor Pharma for $11.7 billion. The deal would give CSL—heavily dependent on vacci...

15 December 2021 Regional News a CSL Behring | Fresenius

Continue Reading →

Europe

VFMCRP AND CARA THERAPEUTICS TO DEVELOP AND COMMERCIALISE CR845 INJECTION FOR CHRONIC KIDNEY DISEASE-ASSOCIATED PRURITUS

Vifor Fresenius Medical Care Renal Pharma (VFMCRP) to develop and commercialise CR845/difelikefalin injection worldwide except in the US, Japan and South Korea for...

23 May 2018 Europe | news care | Fresenius

Continue Reading →

Journal for Clinical Studies

Journal For Clinical Studies has a distinguished editorial advisory board providing the best guidelines for global clinical trials. Your resource for Multisite Studies and emerging markets.

Rare Disease Ebook

Decentralised Clinical Trials in The EU

RWS – eBook

It’s All About Stem Cells

Covid-19

Current Edition

CSL to buy Vifor for $11.7B in biopharma’s largest M&A deal this year

VFMCRP AND CARA THERAPEUTICS TO DEVELOP AND COMMERCIALISE CR845 INJECTION FOR CHRONIC KIDNEY DISEASE-ASSOCIATED PRURITUS

Journal for Clinical Studies